tirzepatide compound banned Beware of Compounded FDA officials warn of fake

The FDAs Adverse Events Reporting System shows hundreds of eye disorder reports tied to Ozempic in 2024 alone, though the agency notes this data requires independent verification

A 2023 study found that people with type 2 diabetes taking GLP-1 drugs had a lower risk of colorectal (colon) cancer compared to those taking other diabetes medications

The FDA's guidelines on dietary supplements further catalyze market expansion, encouraging innovation and safety in product offerings

Barry Conrad got to do it

For temporary blurred vision related to blood sugar fluctuations, the main treatment is patience and stable glucose control

Kalogirou M, Sinakos E